Page last updated: 2024-08-16

propidium and pioglitazone

propidium has been researched along with pioglitazone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kaĭdashev, IP; Kutsenko, NL; Vesnina, LE	1

Other Studies

1 other study(ies) available for propidium and pioglitazone

Article	Year
[Pioglitazone, an activator of PPAR-gamma, reduces the expression of kB nuclear factor and inhibits apoptosis in mononuclear cells of peripheral blood in vitro]. Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994), 2012, Volume: 58, Issue:2 Topics: Adult; Annexin A5; Apoptosis; Cells, Cultured; Dose-Response Relationship, Drug; Female; Flow Cytometry; Gene Expression; Humans; Hypoglycemic Agents; Leukocytes, Mononuclear; NF-kappa B; Pioglitazone; PPAR gamma; Propidium; Receptors, IgG; Thiazolidinediones	2012

Article

Year

[Pioglitazone, an activator of PPAR-gamma, reduces the expression of kB nuclear factor and inhibits apoptosis in mononuclear cells of peripheral blood in vitro].

Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994), 2012, Volume: 58, Issue:2

Topics: Adult; Annexin A5; Apoptosis; Cells, Cultured; Dose-Response Relationship, Drug; Female; Flow Cytometry; Gene Expression; Humans; Hypoglycemic Agents; Leukocytes, Mononuclear; NF-kappa B; Pioglitazone; PPAR gamma; Propidium; Receptors, IgG; Thiazolidinediones

2012